Why the Certificate of Analysis Is Your First Line of Quality Control
When a research peptide arrives in the laboratory, the Certificate of Analysis (COA) is the primary document that connects the physical vial to the analytical data generated during manufacturing. Before any experiment begins, understanding what each section of the COA reports—and what acceptable values look like—allows researchers to make informed decisions about whether a batch is suitable for their intended assay. A COA is not merely a formality; it is an independent record of identity, purity, and quantity that should be reviewed critically rather than accepted at face value.
This guide walks through the key sections found on a well-prepared research peptide COA, explains the analytical methods behind each data point, and highlights the questions a researcher should ask when evaluating a new batch.
Peptide Identity: Sequence and Molecular Weight
The first block of information on any COA should unambiguously identify the compound. This typically includes:
- Full amino acid sequence, written in standard single-letter or three-letter code, including any non-natural residues or post-translational modifications (e.g., phosphorylation, acetylation, amidation).
- Molecular formula and calculated monoisotopic molecular weight, derived directly from the sequence and modification state.
- CAS number or catalog identifier for cross-referencing with published literature.
Confirming that the listed sequence matches the peptide you ordered seems obvious, yet transcription errors do occur. Cross-referencing the molecular weight against a trusted peptide calculator before proceeding to purity data is a worthwhile two-minute check.
Mass Spectrometry: Confirming Molecular Identity
Mass spectrometry (MS) data provides empirical confirmation that the peptide in the vial has the expected molecular mass. Most suppliers report results from electrospray ionization mass spectrometry (ESI-MS) or matrix-assisted laser desorption/ionization (MALDI-MS). What to look for:
- Observed m/z values: ESI-MS often produces multiply charged ions, so the COA should show at least one charge state (e.g., [M+2H]²⁺) with a calculated and observed m/z that agree within ±0.5 Da, or within the instrument's specified mass accuracy (often ±0.1 Da for modern instruments).
- Molecular ion peak [M+H]⁺: For smaller peptides, a singly charged ion is commonly reported. The observed value should fall within acceptable tolerance of the theoretical monoisotopic mass.
- Spectrum or tabular data: A reputable COA includes either a mass spectrum image or a table listing the dominant ion series, not simply a statement that "MS confirmed."
Mass spec confirms identity but does not, on its own, confirm purity. A sample containing a peptide at 60% purity and a co-eluting impurity at 40% can still show a correct mass ion. Purity must be assessed by a separate technique.
Purity Assessment: HPLC Data in Detail
High-performance liquid chromatography (HPLC)—most commonly reversed-phase HPLC (RP-HPLC) with UV detection at 214 or 220 nm—is the standard method for quantifying peptide purity. The COA should report:
- Purity percentage: Expressed as area percentage of the main peak relative to all integrated peaks in the chromatogram. Common research-grade thresholds are ≥95% or ≥98% for structurally sensitive assays.
- Retention time: The time at which the main peptide peak elutes under defined gradient conditions. This is useful for batch-to-batch comparison but is method-dependent.
- Chromatogram: The actual trace should be included or available on request. A well-resolved single dominant peak with only minor shoulders or impurity peaks is the hallmark of a high-purity batch. Be cautious if only a number is provided without supporting chromatographic data.
- Column and gradient conditions: Knowing the stationary phase (e.g., C18), mobile phase system (e.g., water/acetonitrile with 0.1% TFA), and gradient slope allows you to contextualize retention time and, if necessary, reproduce the analysis in-house.
Some COAs report results from two orthogonal HPLC methods (e.g., reversed-phase and ion-exchange), which provides stronger evidence of purity because impurities that co-elute in one system may resolve in another.
Water Content and Net Peptide Content
Lyophilized peptides invariably contain residual water and, depending on the counterion used during purification, trifluoroacetate (TFA) or acetate salt. These contribute to total mass but are not the active peptide. A comprehensive COA addresses this through:
- Karl Fischer titration: Reports moisture content as a weight percentage. Values between 5–12% are typical for lyophilized peptides stored under standard conditions.
- Net peptide content (NPC): The fraction of the total vial mass that represents actual peptide, accounting for water and counterion. NPC can range from roughly 60–90% depending on the peptide's charge state and purification history. This figure is essential for accurate stock solution preparation.
If a COA omits NPC data, researchers should assume that the stated mass includes water and salt contributions, and adjust molar calculations accordingly or request the supporting data from the supplier.
Additional Analytical Endpoints
Depending on the peptide's complexity or intended application, a thorough COA may also include:
- Amino acid analysis (AAA): Hydrolysis of the peptide followed by quantification of individual amino acids confirms composition and can serve as an independent purity check.
- Endotoxin testing: Reported in EU/mg or EU/mL using the limulus amebocyte lysate (LAL) assay; relevant when peptides will be used in cell-based assays where endotoxin contamination could confound results.
- Sterility testing: Occasionally reported for peptides prepared under aseptic conditions for cell culture use.
- Disulfide bond confirmation: For cysteine-containing peptides, Ellman's reagent assay or specific MS fragmentation patterns may be reported to confirm correct disulfide connectivity.
Batch Number, Storage Conditions, and Retest Date
The administrative section of the COA is frequently overlooked but contains operationally important information. The lot or batch number creates a traceable link between the vial and all associated raw analytical data. Recording this number in your laboratory notebook is essential for experimental reproducibility and for filing any quality queries with the supplier. Recommended storage conditions (e.g., −20 °C under inert atmosphere, desiccated) and a retest or expiry date indicate the conditions under which the reported data remain valid. Using a peptide beyond its retest date without re-analysis introduces uncertainty into quantitative experiments.
Evaluating COA Credibility
Not all COAs represent equivalent rigor. When evaluating a supplier's documentation, consider whether: the analytical instrument model and method parameters are specified; spectra and chromatograms are provided rather than summary numbers alone; and an independent or in-house quality assurance signature is present. Requesting a sample COA before placing an order allows researchers to assess documentation quality prior to committing resources.
For research use only. The information presented here is intended to support laboratory scientists in evaluating analytical documentation for in vitro and preclinical research applications. This article does not constitute medical advice and is not intended to guide therapeutic, diagnostic, or human-use decisions of any kind.